Monoclonal antibody M195-I-131
Alternative Names: Anti-CD33 monoclonal antibody-I-131Latest Information Update: 04 Jul 2006
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; PDL BioPharma
- Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action CD33 antigen inhibitors; Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Myeloid leukaemia
Most Recent Events
- 04 Jul 2006 Discontinued - Clinical-Phase-Unknown for Myeloid leukaemia in USA (IV)
- 31 Dec 2001 This agent is still in active development
- 08 Sep 1998 Profile reviewed